Fluid transport in inner ear development

描述(申请人提供)：大约每1000名儿童中就有1人患有遗传性听力损失，SLC26A4突变是遗传性耳聋最常见的已知原因之一。SLC26A4相关性耳聋的高发病率使得研究SLC26A4相关性耳聋的病因成为当务之急，最终目标是制定恢复和保护听力的策略。人类基因SLC26A4和小鼠同源基因SLC26A4编码垂蛋白。在小鼠的研究表明，垂垂蛋白在耳蜗管、前庭迷路和内淋巴囊中是一种氯/碳酸根离子交换器。胚胎发育过程中缺乏膜蛋白会导致内淋巴酸化，前庭迷路的液体分泌与内淋巴囊中依赖膜蛋白的液体吸收不匹配，从而导致膜迷路扩大和耳蜗发育障碍。前庭导水管的扩大，经常与SLC26A4的突变有关，似乎是胚胎发育过程中出现的这种扩大的化石般的记录。胚胎内耳的液体分泌和吸收的机制几乎是未知的。填补我们对内耳发育理解的这一空白，对于开发保护SLC26A4突变患者听力的治疗方法至关重要。我们已经开发了四个特定的目标来解决小鼠模型中最突出的问题：AIM1)-胚胎耳蜗和内淋巴囊中内淋巴的离子组成是什么？这一目标将通过使用离子选择电极测量内耳液的成分来实现。AIM2)调节体液分泌的机制是什么？Aim3)什么机制调节液体吸收？这些目标将通过测试液体分泌和液体吸收的假设模型来实现。候选通道和转运体的起始和表达位置将通过qRT-PCR和免疫细胞化学或原位杂交来确定。选定的模型将在复合突变小鼠身上进行测试。与体液分泌有关的通道或转运蛋白的表达不足有望抑制耳蜗体的扩大，并有可能在没有侧膜蛋白的情况下恢复正常的耳蜗体发育。相反，与液体吸收有关的通道或转运蛋白的表达不足预计会导致在垂蛋白存在的情况下耳蜗增大。目的)仅在内淋巴囊恢复垂蛋白的表达是否足以防止耳蜗增大和耳聋？这一目标将通过培育出仅在内耳内淋巴囊表达垂蛋白的小鼠来实现。研究将包括通过组织学监测耳蜗腔的形成，使用离子选择电极测量耳蜗内电位和内淋巴pH，以及通过听觉脑干记录评估听力。完成这四个目标将建立对耳蜗发育中液体动态平衡的理解，这有望揭示适合于携带SLC26A4突变的个体预防耳聋的治疗策略。 公共卫生相关性：SLC26A4基因突变是幼儿听力损失的最重要原因之一，这种高发病率使我们有必要调查SLC26A4相关耳聋的病因，最终目标是制定策略，恢复和保护受影响的个人的听力。人类基因SLC26A4和小鼠同源基因SLC26A4编码垂蛋白，这种蛋白有助于胚胎内耳的液体运输，这种方式对听力的发育至关重要。这 该提案使用小鼠模型来解决有关胚胎内耳液体运输的基本问题，这对于开发保护SLC26A4突变患者听力的治疗方法至关重要。

DESCRIPTION (provided by applicant): About 1 in 1000 children has hereditary hearing loss with mutations of SLC26A4 being one of the most prevalent known causes of hereditary deafness. The high incidence provides an imperative to investigate the etiology of SLC26A4-related deafness with the ultimate goal to develop strategies to restore and preserve hearing in afflicted individuals. The human gene SLC26A4 and the mouse ortholog Slc26a4 code for pendrin. Studies in mouse have demonstrated that pendrin is a Cl-/HCO3- exchanger in the cochlea, vestibular labyrinth and the endolymphatic sac. Lack of pendrin during embryonic development causes an acidification of endolymph and a mismatch between fluid secretion in the vestibular labyrinth and pendrin-dependent fluid absorption in the endolymphatic sac that leads to an enlargement of the membranous labyrinth and an impairment of cochlear development. The enlarged vestibular aqueduct, frequently associated with mutations of SLC26A4, appears to be a fossil-like record of such an enlargement that was present during embryonic development. Mechanisms of fluid secretion and fluid absorption in the embryonic inner ear are virtually unknown. Filling this gap in our understanding of inner ear development is critical toward the development of treatments to protect hearing in individuals afflicted with mutations of SLC26A4. We have developed four Specific Aims that address the most salient questions in mouse models: Aim1) - what is the ionic composition of endolymph in the embryonic cochlea and the endolymphatic sac? This aim will be addressed by measuring the composition of inner ear fluids with ion-selective electrodes. Aim2) what mechanisms mediate fluid secretion? Aim3) what mechanisms mediate fluid absorption? These aims will be addressed by testing hypothetical models of fluid secretion and fluid absorption. The onset and location of expression of candidate channels and transporters will be determined by qRT-PCR and immunocytochemistry or in-situ hybridization. Selected models will be tested in compound-mutant mice. Deficient expression of channels or transporters implicated in fluid secretion is expected to curb cochlear enlargement and possibly restore normal cochlear development in the absence of pendrin. Conversely, deficient expression of channels or transporters implicated in fluid absorption is expected to cause cochlear enlargement in the presence of pendrin. Aim4) is restoration of pendrin expression solely to the endolymphatic sac sufficient to prevent cochlear enlargement and deafness? This aim will be addressed by generating mice with pendrin expression limited to the endolymphatic sac of the inner ear. Studies will include monitoring cochlear lumen formation by histology, measurements of the endocochlear potential and endolymphatic pH with ion-selective electrodes and evaluating hearing by auditory brain stem recordings. Completion of these four Aims will establish an understanding of fluid homeostasis in cochlear development which holds the promise to reveal treatment strategies that are suitable to prevent deafness in individuals that bear mutations of SLC26A4. PUBLIC HEALTH RELEVANCE: Mutations of the gene SLC26A4 are one of the most important causes of hearing loss in young children and this high incidence provides an imperative to investigate the etiology of SLC26A4-related deafness with the ultimate goal to develop strategies to restore and preserve hearing in afflicted individuals. The human gene SLC26A4 and the mouse ortholog Slc26a4 code for the protein pendrin that contributes to fluid transport in the embryonic inner ear in a way that is critical for the development of hearing. This proposal uses mouse models to address fundamental questions regarding fluid transport in the embryonic inner ear, which is critical for the development of treatments that protect hearing in individuals afflicted with mutations of SLC26A4.